INCR

InterCure Ltd. is a company within the healthcare sector, specifically operating in the drug manufacturers - specialty & generic industry. The company has a market capitalization of $56.87M and employs 320 individuals. From a financial health perspective, InterCure Ltd. has reported negative profitability metrics, including an operating margin of 0.0%, profit margin of -29.2%, and return on equity (ROE) of -16.7%. Additionally, the company's debt to equity ratio is 41.49, indicating that a significant portion of its capital structure is comprised of debt. The current ratio of 1.85 suggests that the company has sufficient liquidity to meet its short-term obligations. In terms of valuation context, InterCure Ltd.'s forward P/E ratio is -0.70 and price to book ratio is 0.14. The company's revenue growth rate (YoY) is 3.4%, which may provide some context for investors evaluating the company's prospects. However, dividend information is not available in the provided data set.